Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    C21

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vicore Hosts Webcast on Buloxibutid and IPF Treatment Trends
    Vicore Hosts Webcast on Buloxibutid and IPF Treatment Trends

    02 Jun 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/vicore-pharma-to-host-webcast-to-discuss-buloxibutid-and-the-evolving-ipf-treatment-l-1172711

    ACCESSWIRE
    02 Jun 2026
    Share Share
    Vicore Pharma Pursues US Dual Listing, Files SEC Registration
    Vicore Pharma Pursues US Dual Listing, Files SEC Registration

    22 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-22/vicore-pharma-pursues-us-dual-listing-files-registration-statement-with-the-sec

    PHARMIWEB
    22 May 2026
    Share Share
    Vicore Pharma Announces Presentations at ATS 2026
    Vicore Pharma Announces Presentations at ATS 2026

    29 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-29/vicore-pharma-announces-presentations-at-the-2026-american-thoracic-society-international-conference

    PHARMIWEB
    29 Apr 2026
    Share Share
    Vicore Completes Enrollment in Phase 2b IPF Trial of Buloxibutid
    Vicore Completes Enrollment in Phase 2b IPF Trial of Buloxibutid

    22 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-22/vicore-pharma-completes-enrollment-in-the-phase-2b-aspire-trial-of-buloxibutid-in-idiopathic-pulmona

    PHARMIWEB
    22 Apr 2026
    Share Share
    2025 Year-End Report
    2025 Year-End Report

    27 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-27/year-end-report-2025

    PHARMIWEB
    27 Feb 2026
    Share Share
    Buloxibutid Granted Orphan Drug Status In Japan For IPF
    Buloxibutid Granted Orphan Drug Status In Japan For IPF

    30 Sep 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/buloxibutid-receives-orphan-drug-designation-in-japan-for-the-treatment-of-idiopathic-1079860

    ACCESSWIRE
    30 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.